1. Merck and Sanofi both buying smaller cancer oncology companies at big premiums — The latest from ASH2019 conference — Biopharma Dive’s drug launch of the year: Zolgensma — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Johnson & Johnson IT


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    3
    Views:
    854
  2. anonymous
    Replies:
    157
    Views:
    51,886
  3. anonymous
    Replies:
    0
    Views:
    453
  4. anonymous
    Replies:
    38
    Views:
    7,591
  5. anonymous
    Replies:
    21
    Views:
    3,634
  6. anonymous
    Replies:
    27
    Views:
    5,327
  7. anonymous
    Replies:
    24
    Views:
    3,880
  8. anonymous
    Replies:
    33
    Views:
    8,819
  9. anonymous
    Replies:
    11
    Views:
    4,735
  10. anonymous
    Replies:
    9
    Views:
    3,092
  11. anonymous
    Replies:
    14
    Views:
    5,342
  12. anonymous
    Replies:
    10
    Views:
    3,399
  13. anonymous
    Replies:
    8
    Views:
    2,335
  14. anonymous
    Replies:
    5
    Views:
    2,196
  15. anonymous
    Replies:
    0
    Views:
    592
  16. anonymous
    Replies:
    8
    Views:
    2,373
  17. anonymous
    Replies:
    2
    Views:
    1,202
  18. anonymous
    Replies:
    2
    Views:
    1,427
  19. anonymous
    Replies:
    5
    Views:
    1,953
  20. anonymous
    Replies:
    9
    Views:
    2,375

Thread Display Options

Loading...